Publications by authors named "Heba AlRajab"
Article Synopsis
- - The study investigates the differences in chronic kidney disease (CKD) management and characteristics between Kuwaiti citizens and expatriates, revealing that expatriates face restricted access to public health services and lower incomes, impacting their health outcomes.
- - Data from 2,610 CKD patients showed that Kuwaitis were older with slightly lower kidney function (eGFR), but exhibited better blood pressure and diabetes control compared to expatriates, who had overall higher kidney function but poorer management of diabetes and hypertension.
- - The conclusion emphasizes that CKD is predominantly caused by diabetes and hypertension, particularly in expatriates, and stresses the need for improved healthcare access, better treatment utilization, and more effective antihypertensive therapies for all patients.
Management of hyperkalemia: Expert consensus from Kuwait - a Modified Delphi Approach.
Int J Nephrol Renovasc Dis
October 2024
Article Synopsis
- - Hyperkalemia, a condition common in heart failure and kidney disease patients using RAAS inhibitors, complicates their treatment; new potassium binders like sodium zirconium cyclosilicate show promise for managing this issue.
- - A panel of twelve experts from Kuwait used a modified Delphi method to reach a consensus on hyperkalemia management, resulting in 44 statements covering treatments for acute cases, heart failure, chronic kidney disease, and hemodialysis.
- - The consensus highlights the inconsistencies in current management guidelines and aims to provide standardized guidance for healthcare practitioners in Kuwait, addressing the treatment gaps in the Arabian Gulf region.
Article Synopsis
- The study investigates the incidence and outcomes of acute kidney injury (AKI) in Kuwait, focusing on differences between Kuwaiti and non-Kuwaiti patients, who face limited access to healthcare.
- A total of 3,744 adult inpatients with AKI were analyzed from seven public hospitals in 2021, revealing that non-Kuwaitis were younger, had better kidney function at baseline, and a higher rate of AKI caused by community factors.
- Despite differences in demographics, there were no significant variations in mortality or kidney recovery rates between the two groups, with a high overall mortality rate of 34.4% among AKI patients within 30 days of hospitalization.
Background: Iron deficiency is common in chronic kidney disease (CKD) patients not on dialysis (ND). Restoring depleted iron stores through intravenous (IV) route is faster and associated with less side effects. There is conflicting data regarding intravenous iron use and its impact on clinical outcomes in this population.
View Article and Find Full Text PDFIntroduction: Hemodialysis (HD) patients are at increased risk of severe COVID-19 infection but infection rates vary. Our objectives are to describe COVID-19 positive HD patients' characteristics, infection rates, and factors associated with mortality in HD COVID-19 cases in Kuwait.
Methods: Data on demographics, comorbidities, and treatments received, as well as mortality for HD patients admitted to hospitals for COVID-19, from 1/March to 31/July 2020, prospectively collected and analyzed.
Objectives: The aim of this study was to review the use rituximab (RTX) and outcomes in immune-mediated glomerular diseases (glomerulonephritis [GN]) and to compare it to the established literature.
Methods: Adult GN patients who received RTX between January 2014 and January 2018 in three public hospitals were reviewed. Membranous nephropathy (MN) and minimal change disease (MCD) were considered diseases with the literature supporting RTX use.
Introduction: COVID-19 infection is associated with high mortality among hemodialysis patients. Standard vaccine response is generally lower among these patients. The adequate antibody titer response and the outcome of COVID-19 vaccine responders versus non-responders are unknown.
View Article and Find Full Text PDFThe total number of end-stage kidney disease patients treated with dialysis in 2019 in Kuwait was 2230, with a 6% increase from the year before. Dialysis prevalence was 465 per million population (PMP) and dialysis incidence was100 PMP. Kuwaiti nationals represented 70% of the dialysis population and males represented 52%.
View Article and Find Full Text PDF